CELUCelularity Inc

Nasdaq celularity.com


$ 3.06 $ 0.10 (3.31 %)    

Thursday, 02-May-2024 15:54:28 EDT
QQQ $ 429.07 $ 5.38 (1.28 %)
DIA $ 382.31 $ 3.34 (0.88 %)
SPY $ 505.01 $ 4.68 (0.94 %)
TLT $ 88.87 $ 0.38 (0.43 %)
GLD $ 213.12 $ -0.66 (-0.31 %)
$ 3.12
$ 3.04
$ 0.00 x 0
$ 0.00 x 0
$ 2.95 - $ 3.06
$ 1.59 - $ 8.90
32,325
na
58.75M
$ 0.63
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 01-03-2024 09-30-2023 10-Q
2 08-14-2023 06-30-2023 10-Q
3 05-22-2023 03-31-2023 10-Q
4 03-31-2023 12-31-2022 10-K
5 11-10-2022 09-30-2022 10-Q
6 08-09-2022 06-30-2022 10-Q
7 05-16-2022 03-31-2022 10-Q
8 03-31-2022 12-31-2021 10-K
9 11-12-2021 09-30-2021 10-Q
10 08-19-2021 06-30-2021 10-Q
11 05-24-2021 03-31-2021 10-Q
12 03-04-2021 12-31-2020 10-K
13 11-16-2020 09-30-2020 10-Q
14 08-13-2020 06-30-2020 10-Q
15 05-15-2020 03-31-2020 10-Q
16 03-24-2020 12-31-2019 10-K
17 11-13-2019 09-30-2019 10-Q
18 08-07-2019 06-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 celularity-says-that-its-expected-net-sales-for-q1-2024-are-trending-ahead-of-the-expectations-it-announced-in-february-for-its-advanced-biomaterial-products-and-biobanking-businesses-implements-planned-2024-sga-reductions-and-manufacturing-ramp-for-advanced-biomaterial-products

Expects the First Quarter of 2024 will be the 4th consecutive quarter of both sequential and quarter-on-quarter net sales growt...

 celularity-to-present-data-showing-senescent-cell-elimination-by-off-the-shelf-natural-killer-cells-derived-from-human-placental-cells

Celularity Inc. (NASDAQ:CELU) ("Celularity"), a biotechnology company developing placental-derived allogeneic cell ther...

 celularity-receives-healthcare-common-procedure-coding-system-q-code-approval-from-the-us-centers-for-medicare--medicaid-services-for-biovance-3l

Celularity Inc. (NASDAQ:CELU) ("Celularity"), a regenerative medicine company developing placental-derived allogeneic c...

 workday-dominos-and-3-stocks-to-watch-heading-into-monday

With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as foll...

 celularitys-tri-layer-decellularized-dehydrated-human-amniotic-membrane-product-investigated-as-a-carrier-of-induced-pluripotent-stem-cell-derived-limbal-stem-cells-in-the-treatment-of-severe-ocular-surface-disease

-Highlights potential uses of Celularity biomaterials in regenerative medicine applications that combine stem cells and biomate...

 dow-jumps-250-points-honeywell-issues-weak-forecast

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 250 points on Thursday. The Dow t...

 why-ch-robinson-shares-are-trading-lower-by-over-12-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-...

 crude-oil-gains-1-ism-manufacturing-pmi-tops-expectations

U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 0.5% on Thursday. The Dow traded up 0.23...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION